This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Forest City Announces Major Office Tenant For Pittsburgh's Station Square

CLEVELAND, June 11, 2012 /PRNewswire/ -- Forest City Commercial Management, Inc. today announced a major tenant signing in one of the company's Pittsburgh-area office properties.

(Logo:  http://photos.prnewswire.com/prnh/20080515/FRSTCTYLOGO )

invivodata, inc. has signed a lease for approximately 28,000 square feet of space in the Commerce Court building located at Station Square, a mixed-use, historic redevelopment area along Pittsburgh's riverfront. invivodata is a fast-paced and innovative technology company that delivers scientific consulting and direct-from-the-patient data collection services to the global pharmaceutical and medical device industry.

Commerce Court is a seven-story, 378,000-square-foot office building that includes ground-floor retail space.

"We are pleased to welcome invivodata to Station Square," said Ed Chanatry, Forest City Commercial Management senior vice president of Asset Management. "As an innovative industry leader in regulated data collection and consulting services, invivodata is a great addition to our office portfolio."

"We are pleased to work with Forest City as we prepare for our expansion into Commerce Court," said Doug Engfer, President and CEO of invivodata.  "This milestone move of our corporate headquarters reflects our rapid growth, positions us to support the continued growth we anticipate,  and reinforces our commitment to the Pittsburgh area."

The landlord was represented by CBRE in the lease negotiations.

About Forest City Commercial Management

Forest City Commercial Management is a subsidiary of Forest City Enterprises, Inc., an NYSE-listed national real estate company with $10.5 billion in total assets. The company is principally engaged in the ownership, development, management and acquisition of commercial and residential real estate and land throughout the United States. For more information, visit www.forestcity.net.

About invivodata

invivodata is the only fully-integrated Clinical Outcomes Assessments (COA) company delivering regulatory-proven strategic consulting and practical electronic solutions to biopharmaceutical companies who depend upon patient-centered research.  From reliable and scientifically sound consulting that helps research teams effectively develop, execute, and document COA strategies to electronically collecting COA data in global clinical development programs, invivodata helps its customers strategically use patient, clinician, and observer reported outcomes data (PROs, ClinROs & ObsROs) to support labeling claims, enhance reimbursement strategies, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies.  invivodata's electronic solutions and strategic consulting services have been used in over 600 clinical projects and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals.  invivodata, inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA.  For more information, visit www.invivodata.com

SOURCE Forest City Enterprises, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs